219 related articles for article (PubMed ID: 19394652)
21. The major endocannabinoid anandamide (AEA) induces apoptosis of human granulosa cells.
Costa L; Moreia-Pinto B; Felgueira E; Ribeiro A; Rebelo I; Fonseca BM
Prostaglandins Leukot Essent Fatty Acids; 2021 Aug; 171():102311. PubMed ID: 34126378
[TBL] [Abstract][Full Text] [Related]
22. Anandamide inhibits adhesion and migration of breast cancer cells.
Grimaldi C; Pisanti S; Laezza C; Malfitano AM; Santoro A; Vitale M; Caruso MG; Notarnicola M; Iacuzzo I; Portella G; Di Marzo V; Bifulco M
Exp Cell Res; 2006 Feb; 312(4):363-73. PubMed ID: 16343481
[TBL] [Abstract][Full Text] [Related]
23. Expression and function of endocannabinoid receptors in the human adrenal cortex.
Ziegler CG; Mohn C; Lamounier-Zepter V; Rettori V; Bornstein SR; Krug AW; Ehrhart-Bornstein M
Horm Metab Res; 2010 Feb; 42(2):88-92. PubMed ID: 19862666
[TBL] [Abstract][Full Text] [Related]
24. Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
Bifulco M; Laezza C; Portella G; Vitale M; Orlando P; De Petrocellis L; Di Marzo V
FASEB J; 2001 Dec; 15(14):2745-7. PubMed ID: 11687506
[TBL] [Abstract][Full Text] [Related]
25. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death.
Athanasiou A; Clarke AB; Turner AE; Kumaran NM; Vakilpour S; Smith PA; Bagiokou D; Bradshaw TD; Westwell AD; Fang L; Lobo DN; Constantinescu CS; Calabrese V; Loesch A; Alexander SP; Clothier RH; Kendall DA; Bates TE
Biochem Biophys Res Commun; 2007 Dec; 364(1):131-7. PubMed ID: 17931597
[TBL] [Abstract][Full Text] [Related]
27. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.
Bermúdez-Siva FJ; Serrano A; Diaz-Molina FJ; Sánchez Vera I; Juan-Pico P; Nadal A; Fuentes E; Rodríguez de Fonseca F
Eur J Pharmacol; 2006 Feb; 531(1-3):282-4. PubMed ID: 16423347
[TBL] [Abstract][Full Text] [Related]
28. Effects of anandamide on polyamine levels and cell growth in human colon cancer cells.
Linsalata M; Notarnicola M; Tutino V; Bifulco M; Santoro A; Laezza C; Messa C; Orlando A; Caruso MG
Anticancer Res; 2010 Jul; 30(7):2583-9. PubMed ID: 20682986
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
30. Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways.
Movsesyan VA; Stoica BA; Yakovlev AG; Knoblach SM; Lea PM; Cernak I; Vink R; Faden AI
Cell Death Differ; 2004 Oct; 11(10):1121-32. PubMed ID: 15375383
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
[TBL] [Abstract][Full Text] [Related]
32. Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.
Barana A; Amorós I; Caballero R; Gómez R; Osuna L; Lillo MP; Blázquez C; Guzmán M; Delpón E; Tamargo J
Cardiovasc Res; 2010 Jan; 85(1):56-67. PubMed ID: 19689982
[TBL] [Abstract][Full Text] [Related]
33. Anandamide improves the impaired nitric oxide-mediated neurogenic relaxation of the corpus cavernosum in diabetic rats: involvement of cannabinoid CB1 and vanilloid VR1 receptors.
Ghasemi M; Sadeghipour H; Dehpour AR
BJU Int; 2007 Dec; 100(6):1385-90. PubMed ID: 17850365
[TBL] [Abstract][Full Text] [Related]
34. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism.
Underdown NJ; Hiley CR; Ford WR
Br J Pharmacol; 2005 Nov; 146(6):809-16. PubMed ID: 16158067
[TBL] [Abstract][Full Text] [Related]
35. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
36. Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk.
Evans RM; Scott RH; Ross RA
Br J Pharmacol; 2007 Oct; 152(3):404-13. PubMed ID: 17700720
[TBL] [Abstract][Full Text] [Related]
37. Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid.
Ronco AM; Llanos M; Tamayo D; Hirsch S
Pharmacology; 2007; 79(1):12-6. PubMed ID: 17114903
[TBL] [Abstract][Full Text] [Related]
38. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum.
Ghasemi M; Sadeghipour H; Mani AR; Tavakoli S; Hajrasouliha AR; Ebrahimi F; Dehpour AR
Eur J Pharmacol; 2006 Aug; 544(1-3):138-45. PubMed ID: 16824514
[TBL] [Abstract][Full Text] [Related]
39. Opposing actions of endocannabinoids on cholangiocarcinoma growth: recruitment of Fas and Fas ligand to lipid rafts.
DeMorrow S; Glaser S; Francis H; Venter J; Vaculin B; Vaculin S; Alpini G
J Biol Chem; 2007 Apr; 282(17):13098-113. PubMed ID: 17329257
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]